1. Home
  2. KRNT vs LXRX Comparison

KRNT vs LXRX Comparison

Compare KRNT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kornit Digital Ltd.

KRNT

Kornit Digital Ltd.

HOLD

Current Price

$15.23

Market Cap

733.1M

Sector

Industrials

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.35

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNT
LXRX
Founded
2002
1995
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
733.1M
703.3M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
KRNT
LXRX
Price
$15.23
$2.35
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$19.75
$4.15
AVG Volume (30 Days)
193.2K
2.9M
Earning Date
05-13-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
$4.52
N/A
Revenue Next Year
$7.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
60.24
52 Week Low
$11.93
$1.00
52 Week High
$21.29
$2.68

Technical Indicators

Market Signals
Indicator
KRNT
LXRX
Relative Strength Index (RSI) 49.37 55.48
Support Level $15.14 $2.04
Resistance Level $16.54 $2.53
Average True Range (ATR) 0.50 0.14
MACD -0.03 -0.00
Stochastic Oscillator 57.69 74.42

Price Performance

Historical Comparison
KRNT
LXRX

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd is a developer and provider of digital solutions for the printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software, and value-added services that enable large-scale printing of short-run complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink, and other consumables, and services, including software subscriptions. The company geographically operates in the U.S., EMEA, Asia Pacific, and other countries. It derives maximum revenue from the U.S.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: